Single award · grant
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
Award ID: R01AG063689
A single federal award, with both ends of the trail linked.
$30.8M
Total award value
Award R01AG063689 is a grant from the Department of Health and Human Services to Brigham & Womens Hospital Inc, $30.8M obligated, FY2019 to FY2026, for Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study. The work is performed in Massachusetts. Source
Award details
Award typeGrant
FAINR01AG063689
Action date2019
Period79 mo
Awarding agencyDepartment of Health and Human Services →
RecipientBrigham & Womens Hospital Inc →
Place of performanceMassachusetts →
Category—
Competed?Not recordedSource
Total (exact)$30,781,439
More awards to Brigham & Womens Hospital Inc
awarded 2007$57.1M
awarded 2011$55.4M
awarded 2000$45.8M
awarded 2007$32.3M
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.